Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Aug 21, 2006

30339_dirs_2006-08-21_ed02f124-6e09-4764-bc2d-559ba97900ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-08-17

Reporting Person: HARGESHEIMER ROBERT S (Div Pres-Pharma Device Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-08-17 Common Stock M 5000 $11.2950 Acquired 39556.3069 Direct
2006-08-17 Common Stock S 5000 $38.1692 Disposed 34556.3069 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-08-17 Stock Option (Right to Buy) $11.2950 M 5000 Disposed 2008-04-28 Common Stock (5000.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4450.8718 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.